NM Patkar, GG Teng, JR Curtis, KG Saag - Current Opinion in Rheumatology, 2008 - journals.lww.com Summary: Although antitumor necrosis factor alpha agents may be independent risk
factors for infections there is an absolute low rate of infection in those
treated with these agents (approximately 5 per 100 patient-years). ... Cited by 16 - Related articles - BL Direct - All 2 versions
- ►prsjournal.net IS Kourbeti, S Tsiodras, DT Boumpas - Current opinion in rheumatology, 2008 - journals.lww.com Recent findings: The range of the pathogens causing spinal infections has
expanded as a result of the increasing number of individuals at risk and
enhanced diagnostics. The role of newer biological therapies in producing ... Cited by 2 - Related articles - All 10 versions
I Therapy - Bloomfield, NJ, Schering Corporation, 1941 - cellestis.com Why does one need to screen for latent TB in individuals needing
immunosuppressive therapy? In patients receiving immune suppressive therapy,
most cases of TB are thought to be due to reactivation of latent TB ... Cited by 1 - Related articles - View as HTML
F Hoentjen, AA van Bodegraven - World Journal of Gastroenterology: WJG, 2009 - pubmedcentral.nih.gov Inflammatory bowel disease (IBD), in particular Crohn's disease refractory to
conventional therapy, fistulizing Crohn's disease and chronic active ulcerative
colitis, generally respond well to anti-tumor necrosis factor (TNF) ... Cited by 1 - Related articles - All 8 versions
JA Leman, AD Burden - Therapeutics and Clinical Risk Management, 2008 - pubmedcentral.nih.gov Psoriasis is a chronic, immune mediated inflammatory disease characterized by
increased cell signalling via cytokines and chemokines on a background of
up-regulated gene expression. There is substantial evidence that psoriasis ... Related articles - All 6 versions
LCR Silva, GG Silveira, M Arnone, R Romiti, … - Archives of Dermatological Research - Springer Abstract Tuberculosis has emerged as a major concern in patients with
immuno-mediated diseases, including psoria- sis, undergoing treatment with
biologicals. However, it is not known whether the chronically activated ... Related articles - All 3 versions
MW Wiedmann, J Mossner, C Baerwald, M … - Endocrine, Metabolic &# 38; Immune Disorders-Drug …, 2009 - ingentaconnect.com Department of Internal Medicine I, St. Mary's Hospital, Gallwitzallee 123-143,
12249 Berlin and Department of Inter- nal Medicine II, University of Leipzig,
Philipp-Rosenthal-Str. 27, 04103 Leipzig, Germany Related articles - All 2 versions
M Cappello, C Randazzo, G Rizzuto, C Bonura, … - Inflammatory Bowel Diseases, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles - All 2 versions
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
J Keane, C NI Cheallaigh - Journal of Rheumatology, 2008 - jrheum.com Until recently the diagnosis and treatment of latent TB infection (LTBI) has
been the preserve of countries with a low prevalence of TB (under 10 patients
per 100,000 population per year). These countries were seeking to eliminate ... Related articles - Cached - All 8 versions
